2027 ICD-10-CM Diagnosis Code E23.3Hypothalamic dysfunction, not elsewhere classified

ICD-10-CM Codes›E00–E89›E20-E35›E23

ICD-10-CM E23.3
CMSSource: CMS FY 2027 ICD-10-CM dataset · Effective Oct 1, 2026 – Sep 30, 2027

E23.3 is a billable ICD-10-CM diagnosis code for hypothalamic dysfunction, not elsewhere classified. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 643 through 645. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Pituitary disorders.

E23.3 no longer risk-adjusts for Medicare Advantage: it mapped to HCC 23 under the retired CMS-HCC V24 model through payment year 2025 but maps to no category in the live V28 model. It still risk-adjusts in the PACE (CMS-HCC V22) category 23, ESRD (V21) category 23, ESRD (V24) category 23, and RxHCC Part D (V08) category 43 for payment year 2027.

Code Identity

ICD-10-CM Code
E23.3
Billable Status
Yes — Valid for Submission
Code Describes
Hypothalamic dysfunction, not elsewhere classified
Short Description
Hypothalamic dysfunction, not elsewhere classified
Same as the full description in the CMS dataset.
Parent Code
E23
Hypofunction and other disorders of the pituitary gland

Code Classification

ChapterE00–E89Endocrine, nutritional and metabolic diseases
SectionE20-E35Disorders of other endocrine glands
CategoryE23Hypofunction and other disorders of the pituitary gland
This CodeE23.3Hypothalamic dysfunction, not elsewhere classified

Medicare Risk Adjustment (HCC)Billing

E23.3 no longer risk-adjusts for Medicare Advantage: it maps to no payment category in the live CMS-HCC V28 model, although it still risk-adjusts in the other CMS models shown below.

CMS-HCC V28 (Medicare Advantage Payment Model)
Not mapped
Dropped in V28 see all codes that no longer risk-adjust
Prior Model (CMS-HCC V24)
HCC 23
V24 retired last contributed to a Medicare Advantage risk score in payment year 2025
Other CMS Models
PACE (CMS-HCC V22): HCC 23 · ESRD (V21): HCC 23 · ESRD (V24): HCC 23
ESRD V21 weights: 0.013 dialysis, 0.234–0.359 functioning graft · ESRD V24 weights: 0.036 dialysis, 0.217–0.390 functioning graft
Part D (RxHCC)
RxHCC 43 — Pituitary, Adrenal Gland, and Other Endocrine and Metabolic Disorders
also risk-adjusts in the Part D prescription drug model (V08)

Source: CMS Payment Year 2027 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Absent osmoregulation
  • Adipsia
  • Amenorrhea due to hypothalamic disorder
  • Amenorrhea due to pituitary dysfunction
  • Central alveolar hypoventilation syndrome
  • Chronic hypernatremia
  • Defective osmoregulation
  • Endocrine axis dysfunction
  • Endocrine menstrual disturbance
  • Exercise induced hypothalamic insufficiency
  • Genetic syndromic childhood obesity
  • Hypernatremia
  • Hypernatremic dehydration
  • Hypoplasia of hypothalamus
  • Hypothalamic adipsic hypernatremia syndrome
  • Hypothalamic amenorrhea
  • Hypothalamic disorder of appetite
  • Hypothalamic overactivity
  • Hypothalamic syndrome
  • Hypothalamic-pituitary-gonadal axis dysfunction
  • Late-onset central hypoventilation co-occurrent and due to hypothalamic dysfunction
  • Loss of hypothalamic inhibition
  • Osmoregulation defect - absent thirst
  • Primary hypothalamic insufficiency
  • Rapid-onset childhood obesity, hypothalamic dysfunction, hypoventilation, autonomic dysregulation syndrome
  • Secondary hypothalamic insufficiency

Instructional NotesGuidance

Instructions from the official ICD-10-CM Tabular List that apply to E23.3: its own notes plus those printed at E23, block E20-E35, and Chapter 4. A note printed at a category, block or chapter applies to every code under it.

Includes

Further defines, or gives examples of, the content of the category.

From E23 Hypofunction and other disorders of the pituitary gland applies to 6 codes
  • the listed conditions whether the disorder is in the pituitary or the hypothalamus

Excludes1

Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.

On E23.3 itself
  • Prader-Willi syndrome (Q87.11)
  • Russell-Silver syndrome (Q87.19)
From E23 Hypofunction and other disorders of the pituitary gland applies to 6 codes
  • postprocedural hypopituitarism (E89.3)
  • short stature due to endocrine disorder (E34.3-)
From Block E20-E35 Disorders of other endocrine glands applies to 99 codes
From Chapter 4 (E00-E89) Endocrine, nutritional and metabolic diseases applies to 973 codes
  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Notes

General instructions on how these codes are used.

From Chapter 4 (E00-E89) Endocrine, nutritional and metabolic diseases applies to 973 codes
  • All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

Source: CMS ICD-10-CM Tabular List. How to read instructional notes.

Referenced in Other NotesGuidance

Instructional notes printed at other codes that name E23.3, its category, or a range that includes it.

Code First 1

These codes say to code first a condition named in the note, and E23.3 is one of the conditions named.

  • G63 Polyneuropathy in diseases classified elsewhere
    endocrine disease, except diabetes (E00-E07, E15-E16, E20-E34) names E20-E34, which includes this code

Notes 1

These notes mention E23.3.

  • Chapter 4 (E00-E89) Endocrine, nutritional and metabolic diseases
    All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere. names E16-E31, which includes this code

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR END013
Pituitary disorders
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Hypothalamic Dysfunction

    a finding of an impairment in the normal processes of the hypothalamus.

Patient EducationClinical

Pituitary Disorders

Your pituitary gland is a pea-sized gland at the base of your brain. The pituitary is the "master control gland" - it makes hormones that affect growth and the functions of other glands in the body.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert E23.3 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
253.9 Pituitary disorder NOS
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2026No changes
FY 2027CurrentCurrent code set, no changesEffective October 1, 2026 through September 30, 2027.

Questions About E23.3Overview

What is the ICD-10 code for hypothalamic dysfunction, not elsewhere classified?

The ICD-10-CM code for hypothalamic dysfunction, not elsewhere classified is E23.3 (sometimes written as E233). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

Is E23.3 (Hypofunction and other disorders of the pituitary gland) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report hypothalamic dysfunction, not elsewhere classified on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

What MS-DRG does E23.3 group to?

When hypothalamic dysfunction, not elsewhere classified is the principal diagnosis on an inpatient stay, it groups to MS-DRG 644, 645, 643, with relative weights from 0.7461 to 1.6138 depending on complications. Higher weights mean higher Medicare reimbursement.

Can E23.3 be reported with Q87.11?

Not as a rule. The Excludes1 note on E23.3 lists "Prader-Willi syndrome (Q87.11)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).

What is the ICD-9 equivalent of E23.3?

Under the General Equivalence Mappings, hypothalamic dysfunction, not elsewhere classified converts to ICD-9-CM 253.9 (pituitary disorder NOS). The mapping is approximate, so confirm the match fits the documentation.

Does E23.3 risk-adjust for Medicare Advantage payment?

Not for Medicare Advantage. E23.3 mapped to HCC 23 in the retired CMS-HCC V24 model, which last determined payment in 2025, but it maps to no category in the live V28 model; see all codes that no longer risk-adjust. It still risk-adjusts in the PACE (CMS-HCC V22) category 23 (Other Significant Endocrine and Metabolic Disorders), ESRD (V21) category 23 (Other Significant Endocrine and Metabolic Disorders), ESRD (V24) category 23 (Other Significant Endocrine and Metabolic Disorders), and RxHCC Part D (V08) category 43 (Pituitary, Adrenal Gland, and Other Endocrine and Metabolic Disorders).